Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Influence of time of day on propofol pharmacokinetics and pharmacodynamics in rabbits.

Bienert A, Płotek W, Zawidzka I, Ratajczak N, Szczesny D, Wiczling P, Kokot ZJ, Matysiak J, Grześkowiak E.

Chronobiol Int. 2011 May;28(4):318-29. doi: 10.3109/07420528.2011.560317.

PMID:
21539423
2.

Pharmacokinetics and pharmacodynamics of propofol in patients undergoing abdominal aortic surgery.

Wiczling P, Bienert A, Sobczyński P, Hartmann-Sobczyńska R, Bieda K, Marcinkowska A, Malatyńska M, Kaliszan R, Grześkowiak E.

Pharmacol Rep. 2012;64(1):113-22.

3.

Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.

Knibbe CA, Zuideveld KP, DeJongh J, Kuks PF, Aarts LP, Danhof M.

Clin Pharmacol Ther. 2002 Dec;72(6):670-84.

PMID:
12496748
4.

A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.

Björnsson MA, Norberg A, Kalman S, Karlsson MO, Simonsson US.

J Pharmacokinet Pharmacodyn. 2010 Jun;37(3):243-55. doi: 10.1007/s10928-010-9157-1. Epub 2010 Apr 23.

PMID:
20414709
5.

Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.

Cox EH, Knibbe CA, Koster VS, Langemeijer MW, Tukker EE, Lange R, Kuks PF, Langemeijer HJ, Lie-A-Huen L, Danhof M.

Pharm Res. 1998 Mar;15(3):442-8.

PMID:
9563075
6.

Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.

Leal N, Calvo R, Agrad FZ, Lukas JC, de la Fuente L, Suarez E.

J Pharm Pharmacol. 2005 Mar;57(3):317-25.

PMID:
15807987
7.

Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.

Bienert A, Wiczling P, Zaba C, Zaba Z, Wolc A, Marciniak R, Grześkowiak E, Kusza K.

Arzneimittelforschung. 2011;61(10):545-52. doi: 10.1055/s-0031-1300552.

PMID:
22164962
8.

Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.

Masui K, Kira M, Kazama T, Hagihira S, Mortier EP, Struys MM.

Anesthesiology. 2009 Oct;111(4):805-17. doi: 10.1097/ALN.0b013e3181b799c1.

PMID:
19741485
9.

Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.

Johnson KB, Egan TD, Kern SE, McJames SW, Cluff ML, Pace NL.

Anesthesiology. 2004 Sep;101(3):647-59.

PMID:
15329589
10.

The influence of the time of day on midazolam pharmacokinetics and pharmacodynamics in rabbits.

Bienert A, Płotek W, Wiczling P, Kostrzewski B, Kamińska A, Billert H, Szczesny D, Zaba C, Teżyk A, Buda K, Bednarek E, Kaliszan R, Grześkowiak E.

Pharmacol Rep. 2014 Feb;66(1):143-52. doi: 10.1016/j.pharep.2013.06.009. Epub 2014 Jan 31.

PMID:
24905320
11.

Propofol in rats: testing for nonlinear pharmacokinetics and modelling acute tolerance to EEG effects.

Ihmsen H, Tzabazis A, Schywalsky M, Schwilden H.

Eur J Anaesthesiol. 2002 Mar;19(3):177-88.

PMID:
12071237
12.

Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats.

Schywalsky M, Ihmsen H, Tzabazis A, Fechner J, Burak E, Vornov J, Schwilden H.

Eur J Anaesthesiol. 2003 Mar;20(3):182-90. Retraction in: Eur J Anaesthesiol. 2010 Apr;27(4):402.

PMID:
12650488
13.

Pharmacokinetics and anesthetic and cardiopulmonary effects of propofol in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus).

Hawkins MG, Wright BD, Pascoe PJ, Kass PH, Maxwell LK, Tell LA.

Am J Vet Res. 2003 Jun;64(6):677-83.

PMID:
12828251
14.

Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil.

Bouillon T, Bruhn J, Radu-Radulescu L, Bertaccini E, Park S, Shafer S.

Anesthesiology. 2002 Dec;97(6):1350-62.

PMID:
12459659
15.

Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.

Vuyk J, Lichtenbelt BJ, Olofsen E, van Kleef JW, Dahan A.

Anesth Analg. 2009 May;108(5):1522-30. doi: 10.1213/ane.0b013e31819e4058.

PMID:
19372331
16.

Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics.

Mertens MJ, Olofsen E, Burm AG, Bovill JG, Vuyk J.

Anesthesiology. 2004 Apr;100(4):795-805.

PMID:
15087613
17.

[Influence of 20% lipid emulsion on drug concentration, distribution volume and pharmacology effect of continuous infusion of propofol in rabbits].

Lu MZ, Kang Y, Chen Y, Wang B, Yin WH, Kang Y.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Jul;44(4):619-23. Chinese.

PMID:
24059121
18.

Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.

Calvo R, Telletxea S, Leal N, Aguilera L, Suarez E, De La Fuente L, Martin-Suarez A, Lukas JC.

Acta Anaesthesiol Scand. 2004 Sep;48(8):1038-48.

PMID:
15315624
19.

The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.

Johnson KB, Egan TD, Kern SE, White JL, McJames SW, Syroid N, Whiddon D, Church T.

Anesthesiology. 2003 Aug;99(2):409-20.

PMID:
12883414
20.

Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery.

Fábregas N, Rapado J, Gambús PL, Valero R, Carrero E, Salvador L, Nalda-Felipe MA, Trocóniz IF.

Anesthesiology. 2002 Dec;97(6):1378-86.

PMID:
12459662

Supplemental Content

Support Center